170 related articles for article (PubMed ID: 9262357)
21. Effects of electrolytic lesion of dorsolateral periaqueductal gray on analgesic response of morphine microinjected into the nucleus cuneiformis in rat.
Haghparast A; Ahmad-Molaei L
Neurosci Lett; 2009 Feb; 451(2):165-9. PubMed ID: 19146915
[TBL] [Abstract][Full Text] [Related]
22. Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat.
Morgan MM; Fossum EN; Levine CS; Ingram SL
Pharmacol Biochem Behav; 2006 Sep; 85(1):214-9. PubMed ID: 16979226
[TBL] [Abstract][Full Text] [Related]
23. Nociceptive facilitating neurons in the rostral ventromedial medulla.
Neubert MJ; Kincaid W; Heinricher MM
Pain; 2004 Jul; 110(1-2):158-65. PubMed ID: 15275763
[TBL] [Abstract][Full Text] [Related]
24. Localization of the antinociceptive and antianalgesic effects of neurotensin within the rostral ventromedial medulla.
Urban MO; Smith DJ
Neurosci Lett; 1994 Jun; 174(1):21-5. PubMed ID: 7970148
[TBL] [Abstract][Full Text] [Related]
25. Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration.
Rosén A; Zhang YX; Lund I; Lundeberg T; Yu LC
Brain Res; 2004 Mar; 1001(1-2):87-94. PubMed ID: 14972657
[TBL] [Abstract][Full Text] [Related]
26. Effects of neurotensin in amygdaloid spatial learning mechanisms.
László K; Tóth K; Kertes E; Péczely L; Ollmann T; Lénárd L
Behav Brain Res; 2010 Jul; 210(2):280-3. PubMed ID: 20219557
[TBL] [Abstract][Full Text] [Related]
27. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat.
Thorat SN; Hammond DL
J Pharmacol Exp Ther; 1997 Dec; 283(3):1185-92. PubMed ID: 9399992
[TBL] [Abstract][Full Text] [Related]
28. The excitatory behavioral and antianalgesic pharmacology of normorphine-3-glucuronide after intracerebroventricular administration to rats.
Smith GD; Smith MT
J Pharmacol Exp Ther; 1998 Jun; 285(3):1157-62. PubMed ID: 9618418
[TBL] [Abstract][Full Text] [Related]
29. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
30. The neurotensin receptor antagonist SR 48692 decreases extracellular striatal GABA in rats.
Chapman MA; See RE
Brain Res; 1996 Aug; 729(1):124-6. PubMed ID: 8874884
[TBL] [Abstract][Full Text] [Related]
31. Neurotensin antagonist acutely and robustly attenuates locomotion that accompanies stimulation of a neurotensin-containing pathway from rostrobasal forebrain to the ventral tegmental area.
Reynolds SM; Geisler S; Bérod A; Zahm DS
Eur J Neurosci; 2006 Jul; 24(1):188-96. PubMed ID: 16882016
[TBL] [Abstract][Full Text] [Related]
32. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
33. The role of neurotensin in positive reinforcement in the rat central nucleus of amygdala.
László K; Tóth K; Kertes E; Péczely L; Lénárd L
Behav Brain Res; 2010 Apr; 208(2):430-5. PubMed ID: 20035801
[TBL] [Abstract][Full Text] [Related]
34. Tolerance to non-opioid analgesics in PAG involves unresponsiveness of medullary pain-modulating neurons in male rats.
Tortorici V; Aponte Y; Acevedo H; Nogueira L; Vanegas H
Eur J Neurosci; 2009 Mar; 29(6):1188-96. PubMed ID: 19302154
[TBL] [Abstract][Full Text] [Related]
35. SR 48692, a specific neurotensin receptor antagonist, has no effect on oesophageal motility in humans.
Zerbib F; Piche T; Charles F; Galmiche JP; Bruley des Varannes S
Aliment Pharmacol Ther; 2004 Apr; 19(8):931-9. PubMed ID: 15080855
[TBL] [Abstract][Full Text] [Related]
36. Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine.
Boules M; Johnston H; Tozy J; Smith K; Li Z; Richelson E
Behav Pharmacol; 2011 Sep; 22(5-6):573-81. PubMed ID: 21691202
[TBL] [Abstract][Full Text] [Related]
37. Participation of central descending nociceptive facilitatory systems in secondary hyperalgesia produced by mustard oil.
Urban MO; Jiang MC; Gebhart GF
Brain Res; 1996 Oct; 737(1-2):83-91. PubMed ID: 8930354
[TBL] [Abstract][Full Text] [Related]
38. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
39. Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.
Bredeloux P; Costentin J; Dubuc I
Behav Brain Res; 2006 Dec; 175(2):399-407. PubMed ID: 17074405
[TBL] [Abstract][Full Text] [Related]
40. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
